Subject: VMGI News Sparks Rally Up 22%

SCV Client Spotlight
VMGI News Sparks Rally Up 22%
Hot Stock to WatchHot Stock to Watch

Company:
Verde Media Group, Inc. (Pink Sheets: VMGI)


Last:

Price: 0.0115

Change (%): + 0.0021 (22.34)

Volume: 22,308,016
VMGI Chart

Verde Media Group Inc. Enters Into Exclusive Licensing Agreement For Needle-Free Injection Technology Adapted To The Beauty Care and Cosmetic Markets

LOS ANGELES, April 10, 2014 /PRNewswire/ -- Verde Media Group Inc. (VMGI) is pleased to announce that it has entered into a licensing agreement through its subsidiary Beautyject, Inc. for the first ever needle-free injection technology adapted to the beauty care and cosmetic markets. As per the agreement Beautyject has the exclusive, perpetual rights to manufacture, market, distribute and sell the products in North, South and Central America.

Beautyject was founded with the mission to provide healthy, effective, skin care and wellness products designed to improve the skin and enhance appearance. Beautyject represents the intersection of where beauty meets technology. Designed to deliver skin care treatments comfortably, accurately and quickly, without the use of a needle, the company will provide clinical grade skin care products to assist physicians and aestheticians with their procedural skin care needs. In addition, Beautyject will also provide products for customers who choose not to have professional treatments, yet want the same results at home for healthier and younger looking skin.

The Beautyject technology can be used to administer selected liquid cosmetic products such as hyaluronic acid, vitamins and botox to the top layers of the skin through a non-invasive, needle-free, painless delivery system called the “Poring Method”. With approximately 5000 uses, consumers, physicians and beauticians can simply re-fill ampoules with their cosmetic treatment of choice. Replaceable adapters and a reusable transporter facilitate fast and easy transfer of the fluid from all the usual types of containers into a sterile ampoule.

The Company’s injectors are superior to conventional needles in many ways and provide benefits to both home users and practitioners. Previously unavailable for private use, individuals can now administer unique formulations to treat superficial lines, minor skin damage, fine wrinkles, moisture and skin elasticity all at the convenience of their homes with no risk of needle stick injuries and damage to the skin. Practitioners benefit from attracting new clientele, new upsell opportunities for existing treatments such as Botox, precision treatment delivery, increased client satisfaction and increased profitability due to complete emptying of ampoules and a longer shelf life.

Continue Reading

Like Us on FacebookFollow Us on Twitter

IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the "unsubscribe" link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks